Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26Q3, 26 TTM Selling/general/admin expenses ——————— — Research & development ——————— — Operating income 413 M716 M517 M923 M552 M714 M611 M 2.8 B Non-Operating Income, Total 37 M11 M36 M-210 M52 M-22 M83 M -97 M Interest expense, net of interest capitalized ——————— — Non-Operating Income, excl. Interest Expenses 20 M-1 M7 M-244 M8 M-33 M49 M -220 M Unusual income/expense 17 M12 M29 M34 M44 M11 M34 M 123 M Pretax income 170 M434 M246 M397 M295 M384 M378 M 1.45 B Equity in earnings ——————— — Taxes ——————— — Non-controlling/minority interest ——————— — After tax other income/expense ——————— — Net income before discontinued operations 125 M408 M212 M615 M266 M392 M307 M 1.58 B Discontinued operations ——————— — Net income 125 M408 M212 M615 M266 M392 M307 M 1.58 B Dilution adjustment ——————— — Preferred dividends ——————— — Diluted net income available to common stockholders 125 M408 M212 M615 M266 M392 M307 M 1.58 B Basic earnings per share (Basic EPS) ——————— — Diluted earnings per share (Diluted EPS) ——————— — Average basic shares outstanding ——————— — Diluted shares outstanding ——————— — EBITDA 1.04 B1.31 B1.13 B1.55 B894 M962 M809 M 4.21 B EBIT 125 M716 M517 M923 M266 M392 M307 M 1.89 B Cost of revenue ——————— — Other cost of goods sold ——————— — Depreciation & amortization (cash flow) 623 M594 M608 M625 M628 M570 M502 M 2.33 B